![]()
|
|
||||||||
(Received for publication, June 4, 1997, and in revised form, August 7, 1997)
From the HIV and AIDS Malignancy Branch, NCI, National Institutes
of Health, Bethesda, Maryland 20892, the § Department of
Pharmacology, School of Medicine, Case Western Reserve University,
Cleveland, Ohio 44106, and the ¶ AIDS Vaccine Program, Science
Applications International Corporation Frederick, Frederick Cancer
Research and Development Center, Frederick, Maryland 21702
Previous studies have suggested that the two
conserved cysteines of the HIV-1 protease may be involved in regulating
protease activity. Here, we examined diglutathionylated wild type
protease (Cys-67-SSG, Cys-95-SSG) and the monoglutathionylated protease mutants (C67A, Cys-95-SSG and C95A, Cys-67-SSG) as potential substrates for thioltransferase (glutaredoxin). Time-dependent changes
in the extent of deglutathionylation of each protein were assayed by reverse phase-high performance liquid chromatography. Glutathione alone was not an effective reductant, whereas thioltransferase displayed differential catalysis toward the Cys-95-SSG and Cys-67-SSG sites. At low thioltransferase concentrations (5 nM),
deglutathionylation occurred almost exclusively at Cys-95-SSG. With
substantially more thioltransferase (100 nM) Cys-67-SSG was
partially deglutathionylated but only at 20% of the rate of Cys-95-SSG
reduction. Treatment of the diglutathionylated protease with
thioltransferase not only restored protease activity but generated an
enzyme preparation that had a 3- to 5-fold greater specific activity
relative to the fully reduced form. Immunoblot analysis of
HIV-1MN virus with an antibody to thioltransferase detected
a band co-migrating with recombinant thioltransferase that persisted
following subtilisin treatment, indicating the presence of
thioltransferase within HIV-1. Our results implicate thioltransferase
in the regulation and/or maintenance of protease activity in HIV-1
infected cells.
This article has been cited by other articles:
![]() |
J. Melchers, N. Dirdjaja, T. Ruppert, and R. L. Krauth-Siegel Glutathionylation of Trypanosomal Thiol Redox Proteins J. Biol. Chem., March 23, 2007; 282(12): 8678 - 8694. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Berndt, C. H. Lillig, and A. Holmgren Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1227 - H1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kanda, Y. Ihara, H. Murata, Y. Urata, T. Kono, J. Yodoi, S. Seto, K. Yano, and T. Kondo Glutaredoxin Modulates Platelet-derived Growth Factor-dependent Cell Signaling by Regulating the Redox Status of Low Molecular Weight Protein-tyrosine Phosphatase J. Biol. Chem., September 29, 2006; 281(39): 28518 - 28528. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Park and M. Levine Cloning, Sequencing, and Characterization of Alternatively Spliced Glutaredoxin 1 cDNA and Its Genomic Gene: CHROMOSOMAL LOCALIZATION, mRNA STABILITY, AND ORIGIN OF PSEUDOGENES J. Biol. Chem., March 18, 2005; 280(11): 10427 - 10434. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lillig, M. E. Lonn, M. Enoksson, A. P. Fernandes, and A. Holmgren Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide PNAS, September 7, 2004; 101(36): 13227 - 13232. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ortega, P. Ferrer, J. Carretero, E. Obrador, M. Asensi, J. A. Pellicer, and J. M. Estrela Down-regulation of Glutathione and Bcl-2 Synthesis in Mouse B16 Melanoma Cells Avoids Their Survival during Interaction with the Vascular Endothelium J. Biol. Chem., October 10, 2003; 278(41): 39591 - 39599. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cartier, B. Hemonnot, B. Gay, M. Bardy, C. Sanchiz, C. Devaux, and L. Briant Active cAMP-dependent Protein Kinase Incorporated within Highly Purified HIV-1 Particles Is Required for Viral Infectivity and Interacts with Viral Capsid Protein J. Biol. Chem., September 12, 2003; 278(37): 35211 - 35219. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Davis, C. A. Brown, F. M. Newcomb, E. S. Boja, H. M. Fales, J. Kaufman, S. J. Stahl, P. Wingfield, and R. Yarchoan Reversible Oxidative Modification as a Mechanism for Regulating Retroviral Protease Dimerization and Activation J. Virol., March 1, 2003; 77(5): 3319 - 3325. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. ROUHIER, E. GELHAYE, and J.-P. JACQUOT Redox Control by Dithiol-Disulfide Exchange in Plants: II. The Cytosolic and Mitochondrial Systems Ann. N.Y. Acad. Sci., November 1, 2002; 973(1): 520 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Furuhata, M. Nakamura, T. Osawa, and K. Uchida Thiolation of Protein-bound Carcinogenic Aldehyde. AN ELECTROPHILIC ACROLEIN-LYSINE ADDUCT THAT COVALENTLY BINDS TO THIOLS J. Biol. Chem., July 26, 2002; 277(31): 27919 - 27926. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Collinson, G. L. Wheeler, E. O. Garrido, A. M. Avery, S. V. Avery, and C. M. Grant The Yeast Glutaredoxins Are Active as Glutathione Peroxidases J. Biol. Chem., May 3, 2002; 277(19): 16712 - 16717. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Shenton, G. Perrone, K. A. Quinn, I. W. Dawes, and C. M. Grant Regulation of Protein S-Thiolation by Glutaredoxin 5 in the Yeast Saccharomyces cerevisiae J. Biol. Chem., May 3, 2002; 277(19): 16853 - 16859. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Davis, E. Read-Connole, K. Pearson, H. M. Fales, F. M. Newcomb, J. Moskovitz, and R. Yarchoan Oxidative Modifications of Kynostatin-272, a Potent Human Immunodeficiency Virus Type 1 Protease Inhibitor: Potential Mechanism for Altered Activity in Monocytes/Macrophages Antimicrob. Agents Chemother., February 1, 2002; 46(2): 402 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Parker and E. Hunter Activation of the Mason-Pfizer monkey virus protease within immature capsids invitro PNAS, November 20, 2001; (2001) 251460998. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sahlin, H. Wang, Y. Stjernholm, M. Lundberg, G. Ekman, A. Holmgren, and H. Eriksson The expression of glutaredoxin is increased in the human cervix in term pregnancy and immediately post-partum, particularly after prostaglandin-induced delivery Mol. Hum. Reprod., December 1, 2000; 6(12): 1147 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Garcia-Pardo, M.D. Granados, F. Gaytan, C.A. Padilla, E. Martinez-Galisteo, C. Morales, J.E. Sanchez-Criado, and J.A. Barcena Immunolocalization of glutaredoxin in the human corpus luteum Mol. Hum. Reprod., October 1, 1999; 5(10): 914 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. KLATT, E. P. MOLINA, M. G. DE LACOBA, C. A. PADILLA, E. MARTÍNEZ-GALISTEO, J. A. BÁRCENA, and S. LAMAS Redox regulation of c-Jun DNA binding by reversible S-glutathiolation FASEB J, September 1, 1999; 13(12): 1481 - 1490. [Abstract] [Full Text] |
||||
![]() |
C. M. Grant, K. A. Quinn, and I. W. Dawes Differential Protein S-Thiolation of Glyceraldehyde-3-Phosphate Dehydrogenase Isoenzymes Influences Sensitivity to Oxidative Stress Mol. Cell. Biol., April 1, 1999; 19(4): 2650 - 2656. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Davis, K. Yusa, L. A. Gillim, F. M. Newcomb, H. Mitsuya, and R. Yarchoan Conserved Cysteines of the Human Immunodeficiency Virus Type 1 Protease Are Involved in Regulation of Polyprotein Processing and Viral Maturation of Immature Virions J. Virol., February 1, 1999; 73(2): 1156 - 1164. [Abstract] [Full Text] |
||||
![]() |
S. Bandyopadhyay, D. W. Starke, J. J. Mieyal, and R. M. Gronostajski Thioltransferase (Glutaredoxin) Reactivates the DNA-binding Activity of Oxidation-inactivated Nuclear Factor I J. Biol. Chem., January 2, 1998; 273(1): 392 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Chrestensen, D. W. Starke, and J. J. Mieyal Acute Cadmium Exposure Inactivates Thioltransferase (Glutaredoxin), Inhibits Intracellular Reduction of Protein-glutathionyl-mixed Disulfides, and Initiates Apoptosis J. Biol. Chem., August 18, 2000; 275(34): 26556 - 26565. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rahlfs, M. Fischer, and K. Becker Plasmodium falciparum Possesses a Classical Glutaredoxin and a Second, Glutaredoxin-like Protein with a PICOT Homology Domain J. Biol. Chem., September 28, 2001; 276(40): 37133 - 37140. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Parker and E. Hunter Activation of the Mason-Pfizer monkey virus protease within immature capsids invitro PNAS, December 4, 2001; 98(25): 14631 - 14636. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |